Karl Simin, PhD
Research Focus - Molecular Pathways of Cancer Malignancy
- Study of breast tumor biology in the context of pRb, p53, and Brca1 loss
- Characterization of transcriptomic signatures of breast atypia
- Use of transgenic mouse models of triple-negative breast cancer
- Elucidation of Dkk and Wnt/β-catenin signaling in cancer
- Use of patient-derived xenograft mouse models from the UMass Cancer Avatar Institute
Representative Publication
Johnson JP, Kumar P, Koulnis M, Patel M, Simin K. Crucial and novel cancer drivers in a mouse model of triple-negative breast cancer. Cancer Genomics Proteomics. 2014;11(3):115-126.